Coffee and the liver: A potential treatment for liver disease?

European Journal of Gastroenterology and Hepatology

Volumn 22, Issue 11, 2010, Pages 1277-1283

  Masterton, Gail Susan ^a   Hayes, Peter C ^b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

caffeine; cirrhosis; coffee; hepatocellular carcinoma; liver disease

Indexed keywords

CAFFEINE;

CANCER RISK; CLINICAL TRIAL; COFFEE; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER FUNCTION TEST; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK REDUCTION;

ANIMALS; ANTICARCINOGENIC AGENTS; CARCINOMA, HEPATOCELLULAR; COFFEE; EVIDENCE-BASED MEDICINE; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; LIVER FUNCTION TESTS; LIVER NEOPLASMS; PROTECTIVE AGENTS; RISK ASSESSMENT; RISK FACTORS;

EID: 78049278834     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32833cca96     Document Type: Review

References (66)

1. Office for National Statistics. Health service quarterly. Winter 2008 2009; 40:59-60.
2. Mukamal KJ, Hallqvist J, Hammar N., Ljung R, Gemes K, Ahlbom A., et al. Coffee consumption and mortality after acute myocardial infarction: the Stockholm Heart Epidemiology Program. Am Heart J 2009; 157:495-501.
3. Friberg E, Orsini N, Mantzoros C.S., Wolk A. Coffee drinking and risk of endometrial cancer-a population-based cohort study. Int J Cancer 2009; 125:2413-2417.
4. Bidel S, Silventoinen K, Hu G., Lee DH, Kaprio J, Tuomilehto J. Coffee consumption, serum gamma-glutamyltransferase and risk of type II diabetes. Eur J Clin Nutr 2008; 62:178-185. (Pubitemid 351234251)
5. Saaksjarvi K, Knekt P, Rissanen H., Laaksonen MA, Reunanen A, Mannisto S. Prospective study of coffee consumption and risk of Parkinson's disease. Eur J Clin Nutr 2008; 62:908-915.
6. Tan EK, Chua E, Fook-Chong SM, Teo Y.Y., Yuen Y., Tan L, Zhao Y. Association between caffeine intake and risk of Parkinson's disease among fast and slow metabolizers. Pharmacogen Genom 2007; 17:1001-1005.
7. Huseby NE, Brenn T, Try K. The Tromso Heart Study: distribution of, and determinants for, gamma-glutamyltransferase in a free-living population. Scand J Clin Lab Invest 1986; 46:63-70.
8. Tanaka K, Tokunaga S, Kono S., Tokudome S, Akamatsu T, Moriyama T., Zakouji H. Coffee consumption and decreased serum gamma-glutamyltransferase and aminotransferase activities among male alcohol drinkers. Int J Epidemiol 1998; 27:438-443.
9. Honjo S, Kono S, Coleman M.P., Shinchi K., Sakurai Y, Todoroki I, et al Coffee consumption and serum aminotransferases in middle-aged Japanese men. J Clin Epidemiol 2001; 54:823-829.
10. Klatsky AL, Morton C, Udaltsova N., Friedman GD Coffee, cirrhosis, and transaminase enzymes. Arch Intern Med 2006; 166:1190-1195.
11. Ikeda M, Maki T, Yin G., Kawate H, Adachi M, Ohnaka K., et al. Relation of coffee consumption and serum liver enzymes in Japanese men and women with reference to effect modification of alcohol use and body mass index. Scand J Clin Lab Invest 2010; 70:171-179.
12. Urgert R, Meyboom S, Kuilman M., Rexwinkel H, Vissers MN, Klerk M, Katan MB Comparison of effect of cafetiere and filtered coffee on serum concentrations of liver aminotransferases and lipids: six month randomized controlled trial. BMJ 1996; 313:1362-1366.
13. Ruhl CE, Everhart JE Coffee and caffeine consumption reduce the risk of elevated serum alanine aminotransferase activity in the United States. Gastroenterology 2005; 128:24-32.
14. Modi AA, Feld JJ, Park Y, Kleiner D.E., Everhart JE, Liang TJ, Hoofnagle JH Increased caffeine consumption is associated with reduced hepatic fibrosis. Hepatology 2010; 51:201-209.
15. Freedman ND, Everhart JE, Lindsay K.L., Ghany MG, Curto TM, Shiffman ML, et al Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C. Hepatology 2009; 50:1360-1369.
16. Klatsky AL, Armstrong MA Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol 1992; 136:1248-1257.
17. Tverdal A, Skurtveit S. Coffee intake and mortality from liver cirrhosis. Ann Epidemiol 2003; 13:419-423.
18. Corrao G, Zambon A, Bagnardi V., D'Amicis A, Klatsky A; Collaborative SIDECIR G. Coffee, caffeine, and the risk of liver cirrhosis. Ann Epidemiol 2001; 11:458-465.
19. Gallus S, Tavani A, Negri E., La Vecchia C. Does coffee protect against liver cirrhosis? Ann Epidemiol 2002; 12:202-205. (Pubitemid 34189722)
20. Inoue M, Yoshimi I, Sobue T., Tsugane S; JPHC Study G. Influence of coffee drinking on subsequent risk of hepatocellular carcinoma: a prospective study in Japan. J Natl Cancer Inst 2005; 97:293-300.
21. Hu G, Tuomilehto J, Pukkala E., Hakulinen T, Antikainen R, Vartiainen E., Jousilahti P. Joint effects of coffee consumption and serum gamma-glutamyltransferase on the risk of liver cancer. Hepatology 2008; 48:129-136.
22. Inoue M, Kurahashi N, Iwasaki M., Shimazu T, Tanaka Y, Mizokami M., et al. Effect of coffee and green tea consumption on the risk of liver cancer: cohort analysis by hepatitis virus infection status. Can Epidemiol, Biomark Preven 2009; 18:1746-1753.
23. Shimazu T, Tsubono Y, Kuriyama S., Ohmori K, Koizumi Y, Nishino Y., et al. Coffee consumption and the risk of primary liver cancer: pooled analysis of two prospective studies in Japan. Int J Can 2005; 116:150-154. (Pubitemid 40827769)
24. Kurozawa Y, Ogimoto I, Shibata A., Nose T, Yoshimura T, Suzuki H., et al. Coffee and risk of death from hepatocellular carcinoma in a large cohort study in Japan. Br J Cancer 2005; 93:607-610.
25. Gelatti U, Covolo L, Franceschini M., Pirali F, Tagger A, Ribero M.L., et al. Coffee consumption reduces the risk of hepatocellular carcinoma independently of its aetiology: a case-control study. J Hepatol 2005; 42:528-534.
26. Montella M, Polesel J, La Vecchia C, Dal Maso L, Crispo A, Crovatto M, et al. Coffee and tea consumption and risk of hepatocellular carcinoma in Italy. Int J Can 2007; 120:1555-1559. (Pubitemid 46355393)
27. Gallus S, Bertuzzi M, Tavani A., Bosetti C, Negri E, La Vecchia C, et al. Does coffee protect against hepatocellular carcinoma? Br J Cancer 2002; 87:956-959. (Pubitemid 35305644)
28. Ohfuji S, Fukushima W, Tanaka T., Habu D, Tamori A, Sakaguchi H., et al. Coffee consumption and reduced risk of hepatocellular carcinoma among patients with chronic type C liver disease: a case-control study. Hepatol Res 2006; 3:201-208.
29. Kuper H, Tzonou A, Kaklamani E., Hsieh CC, Lagiou P, Adami HO, et al Tobacco smoking, alcohol consumption and their interaction in the causation of hepatocellular carcinoma. Int J Can 2000; 85:498-502.
30. Tanaka K, Hara M, Sakamoto T., Higaki Y, Mizuta T, Eguchi Y., et al. Inverse association between coffee drinking and the risk of hepatocellular carcinoma: a case-control study in Japan. Can Sci 2007; 98:214-218.
31. Bravi F, Bosetti C, Tavani A., Bagnardi V, Gallus S, Negri E., et al. Coffee drinking and hepatocellular carcinoma risk: a meta-analysis. Hepatology 2007; 46:430-435.
32. Wakai K, Kurozawa Y, Shibata A., Fujita Y, Kotani K, Ogimoto I., et al. Liver cancer risk, coffee, and hepatitis C virus infection: a nested case-control study in Japan. Br J Cancer 2007; 97:426-428.
33. Ohishi W, Fujiwara S, Cologne J.B., Suzuki G., Akahoshi M, Nishi N, et al Risk Factors for Hepatocellular Carcinoma in a Japanese Population: A Nested Case-Control Study. Cancer Epidemiology Biomarkers Prevention 2008; 17:846-854.
34. Bravi F, Bosetti C, Tavani A., La Vecchia C. Coffee drinking and hepatocellular carcinoma: an update. Hepatology 2009; 50:1317-1318.
35. Spiller MA. The chemical components of coffee. Prog Clin Biol Res 1984; 158:91-147.
36. Serafini M, Testa MF Redox ingredients for oxidative stress prevention: the unexplored potentiality of coffee. Clin Dermatol 2009; 27:225-229.
37. Fukushima Y, Kasuga M, Nakao K., Shimomura I, Matsuzawa Y. Effects of coffee on inflammatory cytokine gene expression in mice fed high-fat diets. J Agric Food Chem 2009; 57:11100-11105.
38. Daglia M, Papetti A, Aceti C., Sordelli B, Gregotti C, Gazzani G. Isolation of high molecular weight components and contribution to the protective activity of coffee against lipid peroxidation in a rat liver microsome system. J Agric Food Chem 2008; 56:11653-11660.
39. Goya L, Delgado-Andrade C, Rufian-Henares JA, Bravo L, Morales FJ Effect of coffee melanoidin on human hepatoma HepG2 cells. Protection against oxidative stress induced by tert-butylhydroperoxide. Mol Nutr Food Res 2007; 51:536-545. (Pubitemid 47083690)
40. Morii H, Kuboyama A, Nakashima T., Kawai K, Kasai H, Tamae K., Hirano T. Effects of instant coffee consumption on oxidative DNA damage, DNA repair, and redox system in mouse liver. J Food Sci 2009; 74:H155-H161.
41. Shi H, Dong L, Zhang Y., Bai Y, Zhao J, Zhang L. Protective effect of a coffee preparation (Nescafe pure(R)) against carbon tetrachloride-induced liver fibrosis in rats. Clin Nutr 2010; 29:399-405.
42. Shin JW, Wang JH, Kang J.K., Son CG Experimental evidence for the protective effects of coffee against liver fibrosis in SD rats. J Sci Food Agric 2010; 90:450-455.
43. Gressner OA, Lahme B, Rehbein K., Siluschek M, Weiskirchen R, Gressner AM Pharmacological application of caffeine inhibits TGF-beta-stimulated connective tissue growth factor expression in hepatocytes via PPARgamma and SMAD2/3-dependent pathways. J Hepatol 2008; 49:758-767.
44. Gressner OA. Less Smad2 is good for you! A scientific update on coffee's liver benefits. Hepatology 2009; 50:970-978.
45. Tao KS, Wang W, Wang L., Cao DY, Li YQ, Wu SX, Dou KF The multifaceted mechanisms for coffee's anti-tumorigenic effect on liver. Med Hypotheses 2008; 71:730-736.
46. Cavin C, Marin-Kuan M, Langouet S., Bezencon C, Guignard G, Verguet C., et al. Induction of Nrf2-mediated cellular defenses and alteration of phase I activities as mechanisms of chemoprotective effects of coffee in the liver. Food Chem Toxicol 2008; 46:1239-1248.
47. Cavin C, Holzhauser D, Constable A., Huggett AC, Schilter B. The coffee-specific diterpenes cafestol and kahweol protect against aflatoxin B1-induced genotoxicity through a dual mechanism. Carcinogenesis 1998; 19:1369-1375.
48. Huber WW, Rossmanith W, Grusch M., Haslinger E, Prustomersky S, Peter-Vorosmarty B, et al. Effects of coffee and its chemopreventive components kahweol and cafestol on cytochrome P450 and sulfotransferase in rat liver. Food Chem Toxicol 2008; 46:1230-1238.
49. Tanaka T, Nishikawa A, Shima H., Sugie S, Shinoda T, Yoshimi N., et al. Inhibitory effects of chlorogenic acid, reserpine, polyprenoic acid (E-5166), or coffee on hepatocarcinogenesis in rats and hamsters. Basic Life Sci 1990; 52:429-440.
50. Okano J, Nagahara T, Matsumoto K., Murawaki Y. Caffeine inhibits the proliferation of liver cancer cells and activates the MEK/ERK/EGFR signalling pathway. Basic Clin Pharmacol Toxicol 2008; 102:543-551.
51. Mascitelli L, Pezzetta F, Sullivan JL Putative hepatoprotective effects of coffee. Aliment Pharmacol Ther 2008; 27:90-91.
52. Jaquet M, Rochat I, Moulin J., Cavin C, Bibiloni R. Impact of coffee consumption on the gut microbiota: a human volunteer study. Int J Food Microbiol 2009; 130:117-121.
53. Palatini P, Ceolotto G, Ragazzo F., Dorigatti F, Saladini F, Papparella I., et al. CYP1A2 genotype modifies the association between coffee intake and the risk of hypertension. J Hypertens 2009; 27:1594-1601.
54. Kokaze A, Ishikawa M, Matsunaga N., Karita K, Yoshida M, Ohtsu T., et al. NADH dehydrogenase subunit-2 237 Leu/Met polymorphism modulates the effects of coffee consumption on the risk of hypertension in middle-aged Japanese men. J Epidemiol 2009; 19:231-236.
55. Hameleers PA, Van Boxtel MP, Hogervorst E, Riedel WJ, Houx P.J., Buntinx F., Jolles J. Habitual caffeine consumption and its relation to memory, attention, planning capacity and psychomotor performance across multiple age groups. Hum Psychopharmacol 2000; 15:573-581.
56. Ogawa N, Ueki H. Clinical importance of caffeine dependence and abuse. Psychiatry Clin Neurosci 2007; 61:263-268.
57. Van Dusseldorp M., Katan MB Headache caused by caffeine withdrawal among moderate coffee drinkers switched from ordinary to decaffeinated coffee: a 12 week double blind trial. BMJ 1990; 300:1558-1559.
58. Kendler KS, Prescott CA Caffeine intake, tolerance, and withdrawal in women: a population-based twin study. Am J Psychiatry 1999; 156:223-228.
59. Pardo Lozano R., Alvarez Garcia Y, Barral Tafalla D, Farre Albaladejo M. Caffeine: a nutrient, a drug or a drug of abuse. Adicciones 2007; 19:225-238.
60. Hughes JR, Oliveto AH, Liguori A, Carpenter J., Howard T. Endorsement of DSM-IV dependence criteria among caffeine users. Drug Alcohol Depend 1998; 52:99-107.
61. Theroux R. Caffeine during pregnancy: how much is safe? Nursing for Women's Health 2008; 12:240-242.
62. Plichart M, Menegaux F, Lacour B., Hartmann O, Frappaz D, Doz F., et al. Parental smoking, maternal alcohol, coffee and tea consumption during pregnancy and childhood malignant central nervous system tumours: the ESCALE study (SFCE). Eur J Can Preven 2008; 17:376-383.
63. Tang N, Wu Y, Ma J., Wang B, Yu R. Coffee consumption and risk of lung cancer: a meta-analysis. Lung Cancer 2010; 67:17-22.
64. Wu JN, Ho SC, Zhou C, Ling W.H., Chen WQ, Wang CL, Chen YM Coffee consumption and risk of coronary heart diseases: a meta-analysis of 21 prospective cohort studies. Int J Cardiol 2009; 137:216-225.
65. Newby DE, Neilson JM, Jarvie D.R., Boon NA Caffeine restriction has no role in the management of patients with symptomatic idiopathic ventricular premature beats. Heart 1996; 76:355-357.
66. Frost L, Vestergaard P. Caffeine and risk of atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Clin Nutr 2005; 81:578-582.